Rating Change
Citizens analysts reiterated a Market Outperform rating on Omada Health (NASDAQ:OMDA) on July 20, 2026.
reiterateNASDAQ:OMDA
Citizens Reiterates Market Outperform Rating on Omada Health (OMDA)
Rating Change Citizens analysts reiterated a Market Outperform rating on Omada Health (NASDAQ:OMDA) on July 20, 2026. Market Context Omada Health operates in the Healthcare…
Market Context
Omada Health operates in the Healthcare sector. The stock currently trades at $23.89 with a market capitalization of $891.5M.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Omada Health.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Omada Health
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 20, 2026 | Citizens | Market Outperform | N/A |
| Jul 17, 2026 | BTIG | Buy | N/A |
| Jun 22, 2026 | Morgan Stanley | Overweight | N/A |
| May 08, 2026 | Citizens | Market Outperform | N/A |
| May 08, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View OMDA Stock Page
Frequently Asked Questions
What does a Market Outperform rating mean for OMDA?
A Market Outperform rating from Citizens reflects the analyst's outlook on Omada Health (NASDAQ:OMDA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OMDA forecast page.